Adquisición de la especialidad farmacéutica PHESGO® 1200 mg/600 mg solución para inyección y PHESGO® 600 mg/600 mg solución para inyección (Pertuzumab/Trastuzumab)
TED · 397507-2026Award noticeawardedNo deadline given
Value
Estimated€2,166,965 · 2,166,965 EUR
Awarded€2,166,965 · 2,166,965.2 EUR
WinnerROCHE FARMA SAU
Who already wins at this buyer
Firms with recorded awards from HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JANSSEN CILAG S.A | 3 | €2,351,724 | 2026-07-30 |
| BRISTOL MYERS SQUIBB S.A.U. | 1 | €2,823,840 | 2026-06-24 |
| ROCHE FARMA SAU | 1 | €1,511,305 | 2026-07-07 |
| VERTEX PHARMACEUTICALS SPAIN, S.L. | 1 | €1,080,664 | 2026-06-29 |
| SANOFI-AVENTIS S.A | 1 | €893,669 | 2026-07-28 |
Full buyer profile: what HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL buys and who wins it →
CPV codes
33140000 Medical equipment & pharmaceuticalsDescription
Adquisición de la especialidad farmacéutica PHESGO® 1200 mg/600 mg solución para inyección y PHESGO® 600 mg/600 mg solución para inyección (Pertuzumab/Trastuzumab). con destino al Servicio de Farmacia del Hospital Universitario Ramón y Cajal
Similar tenders
Closest by meaning — across languages, via embeddings.